Macular Edema: all 848 studies
Page 4 of 9. Open to participants first (57), then studies with results posted, then the rest; newest registration first within each.
- Vitreous Hyper Reflective Dots in Association With Pseudophakic Cystoid Macular EdemaCompletedNCT05811182
- Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular EdemaStatus unknownNCT05759884Not applicable
- Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCTStatus unknownNCT05745116
- Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular EdemaCompletedNCT05736081Phase 4
- IVI Aflibercept Before and After Phaco in DME.CompletedNCT05731089Not applicable
- Comparison of Treatments in Diabetic Macular EdemaCompletedNCT05715385Phase 4
- Safety and Effect of Intravitreal Injection of a Derivative of Nucleoside Reverse Transcriptase Inhibitor in Subjects with Diabetic Macular EdemaCompletedNCT05699759Phase 1
- Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)Active, not recruitingNCT05698329Phase 1
- Aflibercept for Diabetic Macular Edema In Real-life Practice in GREeceCompletedNCT05683912
- VISUPRIME® Eye DropsCompletedNCT05677685Not applicable
- Artificial Intelligence Diagnostic AidStatus unknownNCT05675540
- Application of Artificial Intelligence in Early Detection of Eye Complications in DiabeticsStatus unknownNCT05655117Not applicable
- Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract SurgeryCompletedNCT05626478Phase 4
- The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal InjectionsCompletedNCT05615805Not applicable
- Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to AfliberceptStatus unknownNCT05610488Phase 4
- Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular EdemaActive, not recruitingNCT05608837Phase 2
- Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)Active, not recruitingNCT05607810
- A Post-Authorization, Long-term Study of Ozanimod Real-world SafetyActive, not recruitingNCT05605782
- Additional Effect of Subthreshold Micropulse Laser to Intravitreous Injection of Bevacizumab on Diabetic Macular EdemaStatus unknownNCT05582577Phase 2/3
- The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)CompletedNCT05573100Phase 2
- Comparison of Restoration in Vitreous Hemorrhage Patients With DME After or Not Removing Inner Limiting MembraneStatus unknownNCT05529589
- Special Drug Use Observational Study With Beovu Kit for Intravitreal InjectionCompletedNCT05526729
- A Phase III Study for 601 Versus Ranibizumab in Patients With Vision LossCompletedNCT05520177Phase 3
- Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)Status unknownNCT05496530Not applicable
- Effect of Corona Virus on Intravitreal InjectionsStatus unknownNCT05494775Not applicable
- A Dose Escalation Study of IBI324 in Subjects With Diabetic Macular EdemaCompletedNCT05489718Phase 1
- Real-Life Study in Diabetic Macular EdemaCompletedNCT05472376
- Suprachoroidal Triamcinolone Versus Posterior Subtenon Triamcinolone Alone or Formulated in the Management of Diabetic Macular Edema.CompletedNCT05464953Not applicable
- Comparing Conventional Grid Laser Photocoagulation and Subthreshold Micropulse Laser in Diabetic Macular Edema Using OCT AngiographyStatus unknownNCT05416099
- Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DMEActive, not recruitingNCT05387837Phase 2
- Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein OcclusionsCompletedNCT05385562Not applicable
- Risk Factors for the Recurrent Postoperative Macular Edema Treated With OZURDEXCompletedNCT05372562
- Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening DeviceCompletedNCT05368623
- Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein OcclusionsCompletedNCT05345808Not applicable
- Results of Suprachoroidal Steroids Injections in Two Chorioretinal DiseasesStatus unknownNCT05337332Phase 2/3
- Aqueous Biomarker Levels in Diabetic Retinopathy and Diabetic Macular EdemaTerminatedNCT05333055
- Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular EdemaStatus unknownNCT05324774Phase 3
- Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular EdemaCompletedNCT05324592Phase 1
- Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein OcclusionsStatus unknownNCT05290948Phase 2
- Changes After Suprachoroidal Injection.Status unknownNCT05288192Not applicable
- Ranibizumab Versus Aflibercept for CRVO in Young Patients.Status unknownNCT05282420Phase 4
- Intravitreal Ranibizumab Versus Its Combination With Dexamethasone in The Treatment of Diabetic Macular EdemaCompletedNCT05271539Phase 3
- Home Monitoring of Diabetic Macular EdemaStatus unknownNCT05223569Not applicable
- Macular Thickness and Visual Acuity in Diabetic Hypertensive PatientsStatus unknownNCT05209971
- Oxulumis®, Suprachoroidal Drug Administration of Triesence® in Diabetic Macular EdemaWithdrawnNCT05172401Not applicable
- Effectiveness of Periocular Drug Injection in CATaract SurgeryTerminatedNCT05158699Phase 3
- High Resolution Optical Coherence TomographyStatus unknownNCT05130385
- EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)TerminatedNCT05127525Phase 3
- Optical Coherence Tomography Angiography and Pseudophakic Cystoid EdemaCompletedNCT05117411
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Healthy ParticipantsCompletedNCT05105607Phase 1
- Fundus Image-guided Focal Electroretinography, Usability StudyCompletedNCT05100511Not applicable
- VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization DiseasesActive, not recruitingNCT05099094Early Phase 1
- Combined Intravitreal Bevacizumab With Topical Timolol-Dorzolamide Eye Drops in Diabetic Macular EdemaStatus unknownNCT05083689Phase 2/3
- Diabetic Macular Edema: Relevance of Staging Progression on Therapeutic OutcomeCompletedNCT05080803
- Cystoid Macular Edema After Vitrectomy for Rhegmatogenous Retinal DetachmentStatus unknownNCT05069675
- The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein OcclusionCompletedNCT05038072Not applicable
- Comparing the Compliance to Follow-up in Patients With Diabetic Macular EdemaCompletedNCT05019807Not applicable
- Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients with Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF InjectionCompletedNCT05003258Not applicable
- Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular EdemaTerminatedNCT04991350Phase 4
- BEOVU Versus Eylea in the Treatment of Diabetic Macular EdemaStatus unknownNCT04955171Phase 3
- PCME Prevention in Patients With NPDRCompletedNCT04940338Phase 4
- Impact of the Navilas ® Micropulse Laser Treatment for Macular Edema Within the CHU Brugmann Hospital Macular EdemaCompletedNCT04857099
- Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACSStatus unknownNCT04856670
- Ozurdex in Suboptimal Diabetic Macular Edema PatientsStatus unknownNCT04856397Not applicable
- Non-Responsive Diabetic Macular Edema and SpironolactoneWithdrawnNCT04853355Phase 4
- First-In-Human Study of CU06-1004 Following Single and Multiple Ascending Doses in Healthy VolunteersCompletedNCT04795037Phase 1
- Evaluation of RC28-E Injection in Diabetic Macular EdemaCompletedNCT04782115Phase 2
- Study Comparing Two Populations of Patients Treated With Anti VEGF for Diabetic Macular Edema, One Being Followed at the Hospital and the Other One Being Followed at Home Using a Software Allowing Self-assessment of Visual AcuityStatus unknownNCT04776343Not applicable
- Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening DeviceCompletedNCT04774822
- Smart-TV Application for the Self Examination of the Distance Visual Acuity in Macular Edema PatientsStatus unknownNCT04739137
- Observational Study of Vision Improvement in Patients With Retinal DisordersCompletedNCT04693702
- Prophylactic Effect of Conbercept Intravitreal Injection at the Conclusion of Cataract Surgery for Diabetic Macular EdemaStatus unknownNCT04668703Not applicable
- Diabetic Retinopathy and OCT-A Changes Post-cataract SurgeryStatus unknownNCT04660006
- Obstructive Sleep Apnea and Diabetic Macular Edema Inflammatory MediatorsStatus unknownNCT04648618
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema PatientsCompletedNCT04635800Phase 1
- Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)Status unknownNCT04627402Not applicable
- Bimodal and Coaxial High Resolution Ophtalmic ImagingStatus unknownNCT04620876Not applicable
- Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMOCompletedNCT04619303Phase 4
- Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.Status unknownNCT04601675Not applicable
- A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular EdemaWithdrawnNCT04588948Phase 2
- Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone TherapyCompletedNCT04576689Phase 2
- Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF InjectionsTerminatedNCT04563299Phase 4
- Barriers to Eye Screening for People With Diabetes in IndiaCompletedNCT04544553Not applicable
- Safety and Tolerability Study of UBX1325 in Patients With Diabetic Macular Edema or Neovascular Age-Related Macular DegenerationCompletedNCT04537884Phase 1
- Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping OnlyTerminatedNCT04527523
- A Study to Evaluate THR-149 Treatment for Diabetic Macular OedemaCompletedNCT04527107Phase 2
- Short-pulse Subthreshold vs Infrared Micropulse for Diabetic Macular EdemaCompletedNCT04505306Not applicable
- Evaluation of the Retinal Health Monitoring System Thickness ModuleCompletedNCT04499703
- Intraretinal Cystoid Changes After Vitrectomy With Membrane PeelingCompletedNCT04472039
- A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)Active, not recruitingNCT04469595Phase 4
- Advanced Glycation End Products Are Associated With Diabetic Macular EdemaCompletedNCT04468152Not applicable
- Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular EdemaStatus unknownNCT04464694Phase 4
- Time Efficiency Comparison of Two IntraVitreal Injection TechniquesCompletedNCT04455399Not applicable
- Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular EdemaStatus unknownNCT04448496Phase 4
- Study Evaluating Retinal Health Monitoring System Thickness ModuleWithdrawnNCT04428242
- Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic AgentsCompletedNCT04395859
- COVID-19 Related Lockdown Effects On Chronic DiseasesCompletedNCT04390126
- Effect of the Vitreous in Response to Intravitreal Injections of Ranibizumab for the Treatment of Diabetic Macular EdemaCompletedNCT04387604
- DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract SurgeryStatus unknownNCT04362241Phase 4
- Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular EdemaCompletedNCT04332133Not applicable